VCI Global Completes Founder Group Limited’s IPO on Nasdaq, Records US$5.2 Million in Revenue 24-10-2024, 18:33

EEX and Nasdaq Commodities Announce Intention to Transfer Nasdaq’s European Power Business to EEX 20-06-2023, 15:15

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer 18-01-2024, 11:05